Opinion columnist Tim Culpan joins the program to discuss the future of startups and venture capitalists who found a home in Silicon Valley Bank. Lisa Jarvis with Bloomberg Opinion digs into the Pfizer-Seagen deal, exploring the possibilities for cancer drug development. Opinion's Jonathan Bernstein also joins, weighing the future of the Republican Party should former President Trump be indicted. And columnist Allison Schrager discusses why workers feel so unhappy, despite ample lesiure time.

<p>Opinion columnist Tim Culpan joins the program to discuss the future of startups and venture capitalists who found a home in Silicon Valley Bank. Lisa Jarvis with Bloomberg Opinion digs into the Pfizer-Seagen deal, exploring the possibilities for cancer drug development. Opinion's Jonathan Bernstein also joins, weighing the future of the Republican Party should former President Trump be indicted. And columnist Allison Schrager discusses why workers feel so unhappy, despite ample lesiure time.</p>

Get wide-ranging commentary on the latest in business, economics and politics on the Bloomberg Opinion podcast.

<p>Get wide-ranging commentary on the latest in business, economics and politics on the Bloomberg Opinion podcast.</p>

Wide-ranging commentary on the latest in business, economics and politics.

Bloomberg Opinion

Deeper conversations on the week's most significant developments. Tune in and join in!

In Search of the New SVB and the Future of Cancer Drugs

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9052f832-3239-4071-acd1-afc8009eb797/transcript